John-Paul Bogden

John-Paul Bogden

(604) 631-3375
(604) 631-3309
1133 Melville St, Suite, The Stack, Vancouver, BC
Year called to bar: 1999 (MB); 2000 (BC)
John-Paul (J-P) is a partner in the Blakes Corporate group and focuses on M&A and private equity transactions. He serves as regular M&A counsel to leading financial sponsors and strategic buyers and sellers in Canada, the US and abroad, and is also frequently engaged as special sellside M&A counsel in competitive auction processes. J-P currently serves as co-head of the national Private Equity group and co-head of the Vancouver corporate group, and has served as a member of the Firm’s compensation and partnership committees. J-P is a member of the Canadian Venture Capital and Private Equity Association, the BC Technology Industry Association and the Vancouver chapter of the Association for Corporate Growth.
John-Paul Bogden is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Most Frequently Recommended
Canadian Legal Lexpert Directory
Most Frequently Recommended
Canadian Legal Lexpert Directory
Most Frequently Recommended
Canadian Legal Lexpert Directory
Consistently Recommended
Read more about John-Paul Bogden in ...
British Columbia’s top corporate mid-market lawyers in 2021
Lexpert unveils British Columbia's top corporate mid-market lawyers
PRA Group, Inc. (“PRA Group”), through one of its subsidiaries, completed the acquisition of Resurgent Holdings LLC’s (“Resurgent”) Canadian business. PRA Group is a global leader in acquiring and collecting non-performing loans, and the acquisition supports PRA Group’s position as a market-leading non-performing loan business in Canada.
On May 4, 2018, Frontier Capital completed the acquisition of Agreement Express Inc. and its subsidiary corporations (AEX) through a plan of arrangement. The investment was made through Frontier Capital’s US$700 million Frontier Fund V
On March 21, 2016, a group led by Norwest Venture Partners and including Georgian Partners and BMO Financial Group acquired a significant equity interest in Medgate Inc.